- Home
- POAI vs EVOK Comparison
POAI vs EVOK Comparison
Compare POAI & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- EVOK
- Stock Information
- Founded
- POAI 2002
- EVOK 2007
- Country
- POAI United States
- EVOK United States
- Employees
- POAI N/A
- EVOK N/A
- Industry
- POAI Industrial Specialties
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- EVOK Health Care
- Exchange
- POAI Nasdaq
- EVOK Nasdaq
- Market Cap
- POAI 4.9M
- EVOK 4.3M
- IPO Year
- POAI N/A
- EVOK 2013
- Fundamental
- Price
- POAI $0.69
- EVOK $4.58
- Analyst Decision
- POAI Hold
- EVOK
- Analyst Count
- POAI 1
- EVOK 0
- Target Price
- POAI N/A
- EVOK N/A
- AVG Volume (30 Days)
- POAI 119.5K
- EVOK 1.2M
- Earning Date
- POAI 11-12-2024
- EVOK 11-07-2024
- Dividend Yield
- POAI N/A
- EVOK N/A
- EPS Growth
- POAI N/A
- EVOK N/A
- EPS
- POAI N/A
- EVOK N/A
- Revenue
- POAI $1,484,223.00
- EVOK $8,617,036.00
- Revenue This Year
- POAI N/A
- EVOK $124.10
- Revenue Next Year
- POAI $502.91
- EVOK $75.70
- P/E Ratio
- POAI N/A
- EVOK N/A
- Revenue Growth
- POAI N/A
- EVOK 100.35
- 52 Week Low
- POAI $0.55
- EVOK $3.54
- 52 Week High
- POAI $3.76
- EVOK $17.40
- Technical
- Relative Strength Index (RSI)
- POAI 44.88
- EVOK 39.65
- Support Level
- POAI $0.70
- EVOK $4.03
- Resistance Level
- POAI $0.89
- EVOK $6.09
- Average True Range (ATR)
- POAI 0.11
- EVOK 0.58
- MACD
- POAI 0.00
- EVOK -0.20
- Stochastic Oscillator
- POAI 14.64
- EVOK 20.52
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.